PharmD Info

A forum for Indian Pharmacy Professionals

New Drug Information's and other safety information, drug label changes, and Dose and Dosage Calculations, CDCSO,PvPI and FDA Safety Alerts and etc.
  • User avatar
#2602
The preliminary analysis of SUSARs from the PvPI database reveals that the following drugs are
associated with the risks as given below.

Health care professionals, Patients/Consumers are advised to closely monitor the possibility of the above adverse events associated with the use of above drugs. If such events are encountered please report to the NCC-PvPI either by filling of Suspected Adverse Drug Reactions Reporting Form/ Medicines Side Effect Reporting Form for Consumer (http://www.ipc.gov.in) or by PvPI Helpline No. 1800-180-3024.

Drug Safety Alerts

http://www.ipc.gov.in/PvPI/das.html
Similar Topics
Topics Statistics Last post
PvPI recommendations on drug safety
by venkat  - 24 Dec 2016, 16:40  - In: ADR Monitoring
0 Replies 
2267 Views
by venkat
24 Dec 2016, 16:40
0 Replies 
2620 Views
by Admin
06 Oct 2016, 16:59
0 Replies 
757 Views
by Admin
08 Dec 2020, 14:21
FDA - Drug Safety Podcasts
by unbreakable  - 16 May 2018, 14:40  - In: Drug Information
0 Replies 
4188 Views
by unbreakable
16 May 2018, 14:40
Drug Safety Priorities-2017
by Admin  - 21 Apr 2018, 21:46  - In: Drug Information
1 Replies 
4430 Views
by Krishna K
03 May 2018, 15:00

Urgent hiring Regional Manager (2nd line) with Pha[…]

What is the pathway for a new vaccine introduction[…]

Vacancies for the post of Associate Professor &[…]

Data Analyst (SAS) Team Leader/Associate Manager /[…]

Join Us Today